Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. [electronic resource]
Producer: 20100525Description: 2448-54 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasms, Unknown Primary -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Recurrence
- Retreatment
- Salvage Therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.